Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation

dc.citation.epage131pt_BR
dc.citation.issue2pt_BR
dc.citation.spage120pt_BR
dc.citation.volume40pt_BR
dc.creatorCacemiro, Maira da Costa
dc.creatorCominal, Juçara Gastaldi
dc.creatorRibeiro, Raquel Tognon
dc.creatorNunes, Natalia de Souza
dc.creatorSimões, Belinda Pinto
dc.creatorPontes, Lorena Lôbo de Figueiredo
dc.creatorCatto, Luiz Fernando Bazzo
dc.creatorTraina, Fabíola
dc.creatorSouto, Elizabeth Xisto
dc.creatorZambuzi, Fabiana Albani
dc.creatorFrantz, Fabiani Gai
dc.creatorCastro, Fabíola Attié de
dc.date.accessioned2018-09-13T14:43:27Z
dc.date.available2018-09-13
dc.date.available2018-09-13T14:43:27Z
dc.date.issued2018-04
dc.description.abstractBackground: Cytokines are key immune mediators in physiological and disease processes, whose increased levels have been associated with the physiopathology of hematopoietic malignancies, such as myeloproliferative neoplasms. Methods: This study examined the plasma cytokine profiles of patients with essential thrombocythemia, primary myelofibrosis, polycythemia vera and of healthy subjects, and analyzed correlations with JAK2 V617F status and clinical-hematological parameters. Results: The proinflammatory cytokine levels were increased in myeloproliferative neoplasm patients, and the presence of the JAK2 V617F mutation was associated with high IP-10 levels in primary myelofibrosis patients. Conclusions: Essential thrombocythemia, primary myelofibrosis, and polycythemia vera patients exhibited different patterns of cytokine production, as revealed by cytokine network correlations. Together, these findings suggest that augmented cytokine levels are associated with the physiopathology of myeloproliferative neoplasms.pt_BR
dc.description.resumo-pt_BR
dc.identifier.doihttp://dx.doi.org/10.1016/j.htct.2017.12.003pt_BR
dc.identifier.urihttps://repositorio.ufjf.br/handle/ufjf/7460
dc.languageengpt_BR
dc.publisher-pt_BR
dc.publisher.countryBrasilpt_BR
dc.publisher.initials-pt_BR
dc.relation.ispartofHematology, Transfusion and Cell Therapypt_BR
dc.rightsAcesso Abertopt_BR
dc.subjectPh-negative myeloproliferative neoplasmspt_BR
dc.subjectInflammationpt_BR
dc.subjectPlasma cytokinespt_BR
dc.subjectJAK2 V617Fpt_BR
dc.subject.cnpq-pt_BR
dc.titlePhiladelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulationpt_BR
dc.typeArtigo de Periódicopt_BR

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Philadelphia-negative myeloproliferative.pdf
Size:
1.67 MB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
2.15 KB
Format:
Item-specific license agreed upon to submission
Description: